Fresenius SE & Co. KGaA

  • WKN: 578560
  • ISIN: DE0005785604
  • Land: Deutschland

Nachricht vom 30.06.2021 | 08:48

Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Fresenius SE & Co. KGaA / Total Voting Rights Announcement
30.06.2021 / 08:48
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Publication of total number of voting rights

1. Details of issuer
Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 30.06.2021
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
558040523



30.06.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021